Patient Resources

Marinus Pharmaceuticals is a company of dedicated individuals committed to developing effective treatments for neurological and behavior disorders in adults and children.

Marinus is excited to advance ganaxolone in clinical trials to further research status epilepticus, PCDH19 pediatric epilepsy and Fragile X Syndrome. Below are resources for additional information on these disorders for patients and their families.

Epilepsy Resources:

The Centers for Disease Control and Prevention
National Institute of Neurological Disorders and Stroke
The Epilepsy Foundation
The International League Against Epilepsy (ILAE)

CDKL5 Deficiency Disorder Resources:

CDKL5 Italy
Loulou Foundation
CDKL5 UK
International Foundation for CDKL5 Research

PCDH19 Pediatric Epilepsy Resources:

Boston Children’s Hospital Epilepsy Genetics Program
PCDH19 Epilepsy Registry
Rare Epilepsy Network

Fragile X Syndrome Resources:

The National Fragile X Foundation
FRAXA Research Foundation
National Institutes of Health, Fragile X Syndrome
The Centers for Disease Control and Prevention

CLINICAL TRIALS

Clinical Trial Locator

To search for current ongoing clinical trials please click here
CLINICAL TRIALS